News Sentiment

PROF sentiment intelligence

Profound Medical Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 7.04 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 58

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+3.4% over one week, +6.3% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Profound Medical Corp.

Market Reaction

Balanced read

66/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction 3.4% Price confirming higher
Trend fit Trend inactive 6.3% over four weeks
Fair value -5.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 38
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 58
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 20
Stock Titan 5
TradingView 5
Stock Traders Daily 4
TradingKey 3
Simply Wall Street 3
Investing News Network 3
StockStory 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 24
Guidance 2
Analyst action 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 58
Baystreet.ca Direct company coverage

Profound Medical Corp.

Profound Medical Corp. announced that its TULSA Procedure™ will be featured in multiple presentations by leading physicians at the upcoming Society of Robotic Surgery Annual Meeting in Fort Lauderdale, FL, from July 23-26. Shares of Profound Medical Corp. (T.PRN) were trading up

Tone
Positive 77/100
Event
Market update
Published
15 Jul 2026 14:40
Source
Baystreet.ca
Stock Titan Direct company coverage

Profound Medical's TULSA joins 8-company SRS surgery spotlight

Profound Medical's (NASDAQ:PROF) TULSA Procedure will be prominently featured at the Society of Robotic Surgery (SRS) Annual Meeting in Fort Lauderdale, FL, from July 23-26, 2026. The MRI-guided, AI-powered, robotically driven technology will be highlighted in multiple physician-

Tone
Positive 72/100
Event
Market update
Published
15 Jul 2026 11:40
Source
Stock Titan
TradingView Direct company coverage

Profound Medical to Highlight TULSA Procedure at SRS2026, Multiple Presentations and Investor Session

Profound Medical will showcase its MRI-guided, AI-powered TULSA Procedure at the SRS2026 Annual Meeting through multiple expert presentations and an investor session. The event will feature presentations on real-world and trial outcomes, including primary safety results from the

Tone
Positive 71/100
Event
Earnings
Published
15 Jul 2026 11:40
Source
TradingView
Stock Titan Direct company coverage

Profound Medical (NASDAQ: PROF) plans strong TULSA presence at SRS2026

Profound Medical Corp. announced a significant presence for its TULSA Procedure at the Society of Robotic Surgery Annual Meeting (SRS2026) from July 23-26, 2026, in Fort Lauderdale, FL. The MRI-guided, AI-powered treatment for prostate cancer will be highlighted in multiple physi

Tone
Positive 67/100
Event
Market update
Published
15 Jul 2026 11:40
Source
Stock Titan
Market source Direct company coverage

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026

Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) announced its MRI-guided, AI-powered, Robotically-Driven and Incisionless TULSA Procedure™ will be prominently featured at the Society of Robotic Surgery (SRS) Annual Meeting from July 23-26, 2026. Leading physicians will present on

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 11:40
Source
Market source
Stock Traders Daily Direct company coverage

Discipline and Rules-Based Execution in PROF Response

This article provides an in-depth analysis of Profound Medical Corp. (NASDAQ: PROF), highlighting strong sentiment across all horizons supporting an overweight bias. It outlines distinct institutional trading strategies, including position trading, momentum breakout, and risk hed

Tone
Positive 70/100
Event
Market update
Published
09 Jul 2026 12:18
Source
Stock Traders Daily
TradingView Direct company coverage

Price to earnings forward of Profound Medical Corp – TSX:PRN

This page provides financial information for Profound Medical Corp (TSX:PRN), specifically focusing on its forward price-to-earnings ratio. It indicates that the market is closed with no recent trades for the company. The page also lists various data providers and copyright infor

Tone
Neutral 50/100
Event
Earnings
Published
05 Jul 2026 01:10
Source
TradingView
Stock Traders Daily Direct company coverage

Behavioral Patterns of PROF and Institutional Flows

This article analyzes Profound Medical Corp. (NASDAQ: PROF) using AI models to identify behavioral patterns and institutional flows. It highlights a weak near-term sentiment but strong long-term outlook, with a mid-channel oscillation pattern in play. The analysis provides specif

Tone
Negative 40/100
Event
Guidance
Published
28 Jun 2026 10:50
Source
Stock Traders Daily
TradingView Direct company coverage

PROF Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Profound Medical Corp. (PROF) for 2027, based on analyst opinions. It includes details on the company's financial performance, such as recent earnings and revenue, and addresses frequently asked questions about its stock, incl

Tone
Positive 65/100
Event
Earnings
Published
27 Jun 2026 03:10
Source
TradingView
Market source Direct company coverage

Profound Medical Corp. (PROF) Dropped Despite High Potential

Profound Medical Corp. (PROF) was highlighted by Grow Funds in its Q1 2026 investor letter as a commercial-stage medical device company focused on AI-powered, MRI-guided therapeutic systems for treating prostate cancer. Despite its innovative TULSA-PRO® technology and pipeline of

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 14:28
Source
Market source
TradingKey Direct company coverage

Profound Medical Corp (PROF) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Profound Medical Corp (PROF), detailing its regional revenue contribution. As of the latest disclosure, the company's revenue primarily comes from the USA (76.07%), followed by Canada (19.13%) and Germany (4.80%). Data regarding reven

Tone
Neutral 50/100
Event
Earnings
Published
22 Jun 2026 00:40
Source
TradingKey
TradingKey Direct company coverage

Profound Medical Corp (PROF) Earnings Forecast: Future EPS & Revenue Growth Estimates

Profound Medical Corp (PROF) has an earnings forecast score of 8.80, ranking 10th in the Healthcare Equipment & Supplies industry. Analysts have an average price target of $11.12 with a "Buy" consensus based on 5 analysts. The company's expected revenue for the next quarter is $5

Tone
Positive 66/100
Event
Earnings
Published
17 Jun 2026 21:18
Source
TradingKey
Stock Traders Daily Direct company coverage

(PROF) Movement Within Algorithmic Entry Frameworks

This article provides an algorithmic analysis of Profound Medical Corp. (NASDAQ: PROF), identifying a neutral near and mid-term outlook with a long-term positive bias. It details exceptional short setup risk-reward, outlines specific institutional trading strategies including pos

Tone
Neutral 50/100
Event
Guidance
Published
17 Jun 2026 09:38
Source
Stock Traders Daily
TradingKey Direct company coverage

Profound Medical Corp (PROF) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Profound Medical Corp (PROF), detailing its current price momentum, support and resistance levels, and indicator and moving average readings. It notes that PROF's price momentum score is 6.93, trading between a resistance of 7.16 and

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 22:40
Source
TradingKey
Finviz Direct company coverage

PROF - Profound Medical Corp Stock Price and Quote

This page provides a comprehensive overview of Profound Medical Corp (PROF) stock, including its latest stock price, financial data, company profile, and recent news. It details key financial metrics, stock performance, analyst ratings, and a chronological list of company announc

Tone
Positive 66/100
Event
Analyst action
Published
10 Jun 2026 07:40
Source
Finviz
Simply Wall Street Direct company coverage

Profound Medical (Nasdaq:PROF) - Stock Analysis

This Simply Wall St analysis of Profound Medical (Nasdaq: PROF) highlights its status as a commercial-stage medical device company focused on AI-powered, MRI-guided therapeutic systems. The company shows strong future growth potential with earnings forecast to grow by 54.03% annu

Tone
Positive 62/100
Event
Earnings
Published
04 Jun 2026 18:40
Source
Simply Wall Street
Simply Wall Street Direct company coverage

Profound Medical (TSX:PRN) Stock Forecast & Analyst Predictions

Profound Medical (TSX:PRN) is projected to achieve profitability within the next three years, with analysts forecasting significant growth in earnings and revenue. The company's TULSA-PRO system has shown promising results in clinical trials for prostate cancer and benign prostat

Tone
Neutral 50/100
Event
Earnings
Published
27 May 2026 02:39
Source
Simply Wall Street
Simply Wall Street Direct company coverage

Profound Medical (TSX:PRN) - Stock Analysis

Profound Medical Corp. (TSX:PRN) is a commercial-stage medical device company specializing in AI-powered, MRI-guided therapeutic systems for treating diseased tissue. The company's flagship TULSA-PRO system, used for prostate cancer and BPH, recently demonstrated superior functio

Tone
Neutral 50/100
Event
Market update
Published
27 May 2026 02:09
Source
Simply Wall Street
Stock Titan Direct company coverage

[EFFECT] Profound Medical Corp. SEC Filing

Profound Medical Corp. (NASDAQ: PROF) has announced an SEC Filing for Form EFFECT, indicating the effectiveness of its S-3 Shelf Registration Statement as of May 19, 2026, at 4:30 P.M. The filing shows a neutral impact and sentiment according to Rhea-AI. Profound Medical Corp. ha

Tone
Neutral 50/100
Event
Market update
Published
20 May 2026 10:35
Source
Stock Titan